| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jonathan Gerard, Hsueh Ching Seow, Deborah Hui Yi Tan, Yuen Mei See, Jie Yin Yee, Boon Tat Ng, Charmaine Tang, Jimmy Le. Obsessive-Compulsive Symptoms and Disorder in Clozapine-treated Schizophrenia. Spanish journal of psychiatry and mental health. 2023-11-02. PMID:37918717. |
furthermore, the use of clozapine in treatment-resistant schizophrenia has been thought to induce or aggravate these disorders. |
2023-11-02 |
2023-11-08 |
Not clear |
| Maria Colao, Clara Migotto, Susanna Gilardi, Fulvia Erasmi, Ilaria Borettaz, Marianna Boso, Enrico Giuliani, Renza Tibold. [Clozapine-induced Tubulointerstitial Nephritis]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. vol 40. issue 4. 2023-11-01. PMID:37910212. |
clozapine is a second generation atypical antipsycothic usually used for the treatment of schizophrenia resistant to other types of treatment; it can cause severe adverse effects among which the best known is a severe and potentially fatal neutropenia, furthermore a series of uncommon adverse events are recognized including hepatitis, pancreatitis, vasculitis. |
2023-11-01 |
2023-11-08 |
Not clear |
| Giulia Blandino, Mara Fiorani, Barbara Canonico, Rita De Matteis, Andrea Guidarelli, Mariele Montanari, Gloria Buffi, Lucia Coppo, Elias S J Arnér, Orazio Canton. Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H Redox biology. vol 67. 2023-10-30. PMID:37866162. |
clozapine suppresses nadph oxidase activation, counteracts cytosolic h long-term treatment of schizophrenia with clozapine (clz), an atypical antipsychotic drug, is associated with an increased incidence of metabolic disorders mediated by poorly understood mechanisms. |
2023-10-30 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
it is known that inflammation worsen the course of schizophrenia and induce high clozapine serum levels. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
however, no study evaluated this change in function of clozapine daily dose in schizophrenia. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
we assessed the correlation between inflammation and severity symptoms in patients with schizophrenia that take and do not take clozapine. |
2023-10-26 |
2023-11-08 |
Not clear |
| Chithra Uppinkudru, Vanteemar S Sreeraj, Shyam Sunder Arumugham, Samir K Praharaj, Nishant Goyal, Preeti Sinha, Jagadisha Thirthall. Is ECT better than clozapine for treatment-resistant schizophrenia? Asian journal of psychiatry. vol 90. 2023-10-23. PMID:37871364. |
is ect better than clozapine for treatment-resistant schizophrenia? |
2023-10-23 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. |
2023-10-16 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
here, we aim to evaluate the physical health effects of a nurse-led non-pharmacological intervention program in patients with a diagnosis of schizophrenia treated with clozapine. |
2023-10-16 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
thirty-one outpatients from the outpatient clinical facility of hospital clinic in barcelona, spain diagnosed with schizophrenia and other psychotic disorders receiving clozapine treatment were enrolled in a prospective interventional study, comprising an 8-week group program of therapeutic education in a healthy lifestyle. |
2023-10-16 |
2023-11-08 |
Not clear |
| Jonathan G Leung, Lusi Zhang, Matej Markota, Vicki L Ellingrod, Danielle J Gerberi, Jeffrey R Bisho. A systematic review of clozapine-associated inflammation and related monitoring. Pharmacotherapy. 2023-10-16. PMID:37842767. |
clozapine is an effective antipsychotic medication used for treatment-resistant schizophrenia. |
2023-10-16 |
2023-11-08 |
Not clear |
| Kira Griffiths, Maria Ruiz Mellado, Raymond Chung, John Lally, Grant McQueen, Kyra-Verena Sendt, Amy Gillespie, Muhammad Ibrahim, Alex Richter, Adrian Shields, Mark Ponsford, Stephen Jolles, John Hodsoll, Thomas Pollak, Rachel Upthegrove, Alice Egerton, James H MacCab. Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain, behavior, and immunity. 2023-10-13. PMID:37832895. |
changes in immunoglobulin levels during clozapine treatment in schizophrenia. |
2023-10-13 |
2023-10-15 |
Not clear |
| Kira Griffiths, Maria Ruiz Mellado, Raymond Chung, John Lally, Grant McQueen, Kyra-Verena Sendt, Amy Gillespie, Muhammad Ibrahim, Alex Richter, Adrian Shields, Mark Ponsford, Stephen Jolles, John Hodsoll, Thomas Pollak, Rachel Upthegrove, Alice Egerton, James H MacCab. Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain, behavior, and immunity. 2023-10-13. PMID:37832895. |
use of clozapine in treatment-resistant schizophrenia is often limited due to risk of adverse effects. |
2023-10-13 |
2023-10-15 |
Not clear |
| Zixu Yang, Hiroyoshi Takeuchi, Jie Yin Yee, Yuen Mei See, Charmaine Tang, Boon Tat Ng, Jimmy Le. Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore. Schizophrenia research. 2023-10-13. PMID:37833207. |
clozapine is recognized as the gold standard medication for treatment-resistant schizophrenia. |
2023-10-13 |
2023-10-15 |
Not clear |
| Isabella Berardelli, Mariarosaria Cifrodelli, Carlotta Giuliani, Giulia Antonelli, Carolina Putotto, Federica Pulvirenti, Maurizio Pompil. Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series. International clinical psychopharmacology. 2023-10-12. PMID:37824335. |
furthermore, in our patients, the clinical effectiveness was achieved with a very low dose of clozapine (<150 mg/day) concerning the standard dose used in idiopathic schizophrenia (>300 mg/day to 600 mg/day). |
2023-10-12 |
2023-10-15 |
Not clear |
| Francesco Franza, Annalisa Soddu, Nicoletta Fiorentino, Luigi Calabrese, Albino Zarrella, Barbara Solomita, Giuseppe Tavormin. The Interference of Negative Symptoms of Schizophrenia on Cognitive Domains: a Long-Term Observational Study on the Role of Clozapine. Psychiatria Danubina. vol 35. issue Suppl 2. 2023-10-06. PMID:37800215. |
the interference of negative symptoms of schizophrenia on cognitive domains: a long-term observational study on the role of clozapine. |
2023-10-06 |
2023-10-07 |
Not clear |
| Francesco Franza, Annalisa Soddu, Nicoletta Fiorentino, Luigi Calabrese, Albino Zarrella, Barbara Solomita, Giuseppe Tavormin. The Interference of Negative Symptoms of Schizophrenia on Cognitive Domains: a Long-Term Observational Study on the Role of Clozapine. Psychiatria Danubina. vol 35. issue Suppl 2. 2023-10-06. PMID:37800215. |
our small 5-year observational study evaluated the efficacy of clozapine in negative and cognitive symptoms in schizophrenia inpatients. |
2023-10-06 |
2023-10-07 |
Not clear |
| Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, Chak Fai Ma, Johnny Siu Wah Chun, Albert Kar Kin Chung, Sherry Kit Wa Cha. A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia. Schizophrenia research. 2023-10-03. PMID:37788946. |
a systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia. |
2023-10-03 |
2023-10-07 |
Not clear |
| Natalie Kwok Wing Cheuk, Wing Tse, Harry Kam Hung Tsui, Chak Fai Ma, Johnny Siu Wah Chun, Albert Kar Kin Chung, Sherry Kit Wa Cha. A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia. Schizophrenia research. 2023-10-03. PMID:37788946. |
this study aimed to conduct a systematic review and meta-analysis on cognitive performances of patients with treatment-resistant schizophrenia (trs) after clozapine treatment and to examine the potential effect of follow-up duration and clozapine dosage. |
2023-10-03 |
2023-10-07 |
Not clear |